A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.
about
Placebo response and remission rates in randomized trials of induction and maintenance therapy for ulcerative colitisBudesonide for maintenance of remission in Crohn's diseaseBudesonide for maintenance of remission in Crohn's diseaseRosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.Limitations in assessment of mucosal healing in inflammatory bowel diseaseThe placebo effect: illness and interpersonal healing.European evidence-based Consensus on the management of ulcerative colitis: Current management.Patient preferences for surgical versus medical therapy for ulcerative colitis.Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study.Maintenance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): a systematic review and meta-analyses.Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitisPlacebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trialsMeta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease.A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research.Mucosal healing in inflammatory bowel disease-a true paradigm of success?Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.Safety and efficacy of Profermin® to induce remission in ulcerative colitis.Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study.Ulcerative proctitis: a review of pharmacotherapy and management.Voting With their Feet (VWF) endpoint: a meta-analysis of an alternative endpoint in clinical trials, using 5-ASA induction studies in ulcerative colitis.Controversies in mucosal healing in ulcerative colitis.A primer on effectiveness and efficacy trialsSecond Korean guidelines for the management of ulcerative colitis.Capsule endoscopy and Crohn's disease.Treatment of IBD: where we are and where we are going.Clinical trials in ulcerative colitis: a historical perspective.Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.A critical review of endoscopic indices in ulcerative colitis: inter-observer variation of the endoscopic index.Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases.Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's disease.3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial.Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.Designing fecal microbiota transplant trials that account for differences in donor stool efficacy.Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis.Mesalamine dose escalation reduces fecal calprotectin in patients with quiescent ulcerative colitis.Use of new once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis: Is there anything new under the sun?A two-way enriched clinical trial design: combining advantages of placebo lead-in and randomized withdrawal.Erythrocytes-mediated delivery of dexamethasone 21-phosphate in steroid-dependent ulcerative colitis: a randomized, double-blind Sham-controlled study.Randomized clinical trial: atorvastatin versus placebo in patients with acute exacerbation of mild to moderate ulcerative colitis.Association between psychological measures with inflammatory anddisease-related markers of inflammatory bowel disease.
P2860
Q24187737-ADB28A78-EC5C-4430-B06B-7DDA7DD86663Q24194313-B642BF67-6A26-4736-9CBB-068438EBD090Q24241252-C672E791-1376-4ECA-85D8-0CD98D996605Q30440147-2EDBE5A2-12F2-4A2D-ADEE-3DB2018BFB4EQ33564957-252C9698-B1E5-47E7-84E6-5CE108051A00Q33621740-F32108FD-0646-436F-B5B9-F339C9AC61FBQ34025054-BAC312B7-2C15-4128-8E44-C1AF2553BC61Q34065549-13989ED5-3C4C-4B71-B531-37B6927C2B08Q34507117-054F8511-F9B4-4919-B567-4FE249312D5CQ34620794-CAABA4E8-62B9-4D9B-AE55-0D891FD489C3Q35069498-90B8D864-37DC-49EF-985A-CDE85A810B62Q35098246-F15FB935-15B2-4E24-8754-10D7F123E184Q35147233-50893E7A-FBA7-40AA-9986-D6A41A8AAD08Q35169255-4E9DFD02-B461-4808-B123-64E9B607EAA8Q35749943-3BAD098E-7E29-4C78-8CF2-09B6B5D09D55Q35889006-972BFC74-27D4-420C-A8DD-C66F332E8126Q35904302-CDF37611-EDE5-4F31-8BD5-5821B1A0A03EQ37047522-E4688662-4EE5-4CF3-B14A-6F6CB166F49CQ37111844-E20BE35A-69BC-4FEC-830D-FBFA78752385Q37341884-C2C48BB6-444F-4E7E-A5D5-740470AAD7C3Q37391543-219AAF61-EE00-4B98-9281-1EBD4A7008E6Q37549837-F7B8F7E3-A07D-45AA-89F1-5D14D088C976Q37662503-9941D0D4-9754-4707-AD02-571D25B89EF1Q37959211-77877314-9DDB-4D12-AE6E-8417CE5FEDACQ38285619-99A2AF53-8C1B-4698-BECA-5D6CE6642E2EQ38443024-B3B1BDDC-00DF-4D69-BD4F-940D9A789A19Q38531008-D92F4AEC-A8DD-441A-B328-417335E9679FQ38550845-5E123427-BEB5-4106-9877-13E91E37C56FQ38943959-AE0586D3-4BF7-41DB-A222-7A959083E45DQ39121473-23589D16-5E5C-425D-B86C-C1F592F25348Q39977343-34381B74-B407-4F7E-A628-C1E3843CFCA5Q40295402-097BB96C-3E5E-48B4-A92C-8D3D1984684FQ40339859-7229349F-92CD-48D8-A4B1-5E36ED0F5ABEQ41128447-C9EFB4F8-1826-4CE1-B9EC-5EC84A8D6876Q41821193-C0EBE45D-1638-4E82-9B43-55F291C71526Q43144390-1B342ABB-A458-4A88-A4E2-9801D68431AAQ44216589-D44C9687-D77A-49BD-B8F5-0B8EE5F6E27BQ45124275-E3ACEE5B-3E26-43A4-9045-BCBA757F19DDQ45852639-B0B9B8A3-9F69-4AAC-B6D0-055E8341FA7BQ47931392-089C30B5-0636-451F-80E9-28D700C32753
P2860
A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A meta-analysis of the placebo ...... of active ulcerative colitis.
@ast
A meta-analysis of the placebo ...... of active ulcerative colitis.
@en
type
label
A meta-analysis of the placebo ...... of active ulcerative colitis.
@ast
A meta-analysis of the placebo ...... of active ulcerative colitis.
@en
prefLabel
A meta-analysis of the placebo ...... of active ulcerative colitis.
@ast
A meta-analysis of the placebo ...... of active ulcerative colitis.
@en
P2093
P1433
P1476
A meta-analysis of the placebo ...... of active ulcerative colitis.
@en
P2093
Brittany Goldberg
Colleen Brensinger
Gary R Lichtenstein
James D Lewis
P304
P356
10.1053/J.GASTRO.2006.12.037
P407
P577
2006-12-20T00:00:00Z